文献
J-GLOBAL ID:201702289475539392
整理番号:17A1065137
濾胞性リンパ腫(SABRINA)の一次治療のためのリツキシマブ皮下対リツキシマブ静脈内投与の有効性と安全性:無作為化,非盲検,第3相試験【Powered by NICT】
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
著者 (14件):
Davies Andrew
(Cancer Research UK Centre, Faculty of Medicine, University of Southampton, Southampton, UK)
,
Merli Francesco
(Haematology, Azienda Ospedaliera Santa Maria Nuova IRCCS, Reggio Emilia, Italy)
,
Mihaljevic Biljana
(Clinic of Haematology, Clinical Centre Serbia School of Medicine, Belgrade, Serbia)
,
Mercadal Santiago
(Catalan Institute of Oncology, Barcelona, Spain)
,
Siritanaratkul Noppadol
(Division of Haematology, Department of Medicine, Siriraj Hospital, Bangkok, Thailand)
,
Solal-Celigny Philippe
(Centre Jean Bernard, Le Mans, France)
,
Boehnke Axel
(Clinical Development, F Hoffmann-La Roche, Basel, Switzerland)
,
Berge Claude
(Clinical Development, F Hoffmann-La Roche, Basel, Switzerland)
,
Genevray Magali
(Safety Risk Management, F Hoffmann-La Roche, Basel, Switzerland)
,
Zharkov Artem
(Safety Risk Management, F Hoffmann-La Roche, Basel, Switzerland)
,
Dixon Mark
(Biometrics, Roche Products, Welwyn Garden City, UK)
,
Brewster Michael
(Clinical Development, Roche Products, Welwyn Garden City, UK)
,
Barrett Martin
(Clinical Development, Roche Products, Welwyn Garden City, UK)
,
MacDonald David
(QEII Health Sciences Centre, Halifax, NS, Canada)
資料名:
Lancet Haematology
(Lancet Haematology)
巻:
4
号:
6
ページ:
e272-e282
発行年:
2017年
JST資料番号:
W3150A
ISSN:
2352-3026
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)